474 Results (Page 16 of 19)
Egypt Markets Research Reports
Egypt Sickle Cell Disease Drugs Market Analysis
Egypt Sickle cell disease Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Sickle cell disease Drugs is growing rapidly as a result of increasing prevalence of sickle cell disease , increasing investment for healthcare infrastructure, increase in the number of research and development activities, Support provided by governments of different countries, patient advocacy programmes and incentives provided by regulatory authorities. Global Blood Therapeutics, Novartis, Emmaus Life Sciences, Bluebird Bio, Teva Pharmaceutical Industries Ltd, Pfizer Inc., Mylan N.V., Merck & Co., Inc., Johnson & Johnson Private Limited, Bristol-Myers Squibb Company, AbbVie Inc are the key global market players operating in sickle cell disease Drugs market.
Egypt Soft Tissue Sarcoma Market Analysis
Egypt Soft Tissue Sarcoma market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Soft Tissue Sarcoma is growing rapidly as a result of increasing prevalence and incidence of soft tissue sarcoma, rising awareness about the disease, rising research and development activities on drugs and other therapies, increase in partnerships between pharmaceutical companies for drug development and advancements in diagnostics. Pfizer Inc, Eli Lilly and Company, Johnson & Johnson, Bayer AG, Eisai Co., Ltd., Epizyme, Inc., Adaptimmune Therapeutics, Mylan N.V., Sanofi are the key market players operating in global Soft Tissue Sarcoma market.
Egypt Wilson's Disease Drugs Market Analysis
Egypt Wilson?s Disease Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Wilson?s Disease Drugs is growing rapidly as a result of rising prevalence of the disease, advancements in diagnostic techniques , increase in awareness about the disease due to patient advocacy programmes , support and incentives from regulatory authorities like incentives and orphan drug designations and increasing investment in research and development activities. Amneal Pharmaceuticals, Meda Pharmaceuticals, Teva Pharmaceuticals Industries Ltd. , Taj Pharmaceutical Limited, Ipsen Pharma, TSUMURA & CO., Mylan pharmaceuticals are the key global market players in wilson?s disease drugs market.
Egypt X-Linked Myotubular Myopathy (XLMTM) Drugs Market Analysis
Egypt X-Linked Myotubular Myopathy (XLMTM) Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for X-Linked Myotubular Myopathy (XLMTM) Drugs is growing rapidly as a result of unmet medical need for therapies of X-Linked Myotubular Myopathy (XLMTM) disease, advancements in gene therapy, Growing Awareness and Patient Advocacy about the disease, Increased Research and Collaboration between research organizations and pharmaceutical companies, supportive regulatory environments, Technological Advancements in gene sequencing and biomarker identification. Novartis Gene Therapies, Avrobio, Axovant Gene Therapies, Sarepta Therapeutics, Amicus Therapeutics, Sanofi Genzyme, Pfizer, Audentes Therapeutics are the key market players operating in global X-Linked Myotubular Myopathy (XLMTM) Drugs market.
Egypt Acromegaly Therapeutics Market Analysis
Egypt Acromegaly Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The prevalence and incidence of acromegaly and pituitary tumours are rising, as is global awareness of the disease. Technological advances in the development of new acromegaly medications are also key contributors to the market's growth. The high prevalence of hormonal problems, evolving lifestyles, and rising genetic disease incidence are all anticipated to fuel market expansion.Some of the key players in the global acromegaly therapeutics Market include Roche, Sanofi, GSK, Pfizer INC., Ipsen, Chiasma Inc, Validus pharmaceuticals LLC., Novartis AG, Amryt, Recordati, Sun Pharma, Crinetics Pharmaceuticals, Camurus, Ionis Pharmaceuticals , and Others.
Egypt Adrenoleukodystrophy (ALD) Therapeutics Market Analysis
Egypt Adrenoleukodystrophy (ALD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Drivers of acromegaly market are increasing cases of the disorder which in turn increased awareness and government focus motivated financial support to R&D. Poxel SA, Bluebird Bio Inc.,Viking Technologies, Minoryx Therapeutics sl., Apteeus SAS, Ashvattha Therapeutics LLC, NeuroVia Company, Autobahn Therapeutics Inc., Aldagen Inc., Celularity Inc., Imstem Biotechnology Inc., MedDay SA, and Orpheris Inc. are major competitors in the Egypt Adrenoleukodystrophy (ALD) drugs market.
Egypt Alport Syndrome Therapeutics Market Analysis
Egypt during the forecast period of 2023-30, the Alport Syndrome therapeutics market is anticipated to increase from $xx Mn in 2023 to $xx Mn by 2030, recording a CAGR of xx percent. Almost always affecting the kidney, Alport syndrome is a multisystem condition that also usually affects the inner ear and the eye. A variety of symptoms that normally start in childhood or adolescence and may get worse over time can be present. Invitae Corporation, Hoffmann-La Roche Ltd., Centogene N.V., and Eurofins Discovery are a few of the leading companies in the worldwide Alport syndrome market.
Egypt Anal Fistula Therapeutics Market Analysis
Egypt During the forecast period of 2023?2030, the Anal Fistula Therapeutics Market is anticipated to increase from $xx Mn in 2023 to $xx Mn by 2030, recording a CAGR of xx percent. A rare intestinal ailment that typically appears following an acute perianal abscess and is defined by improper connection between the lower rectum and the perianal skin. The market is expanding more quickly thanks to technological advancements in anal fistula therapy. The development of novel surgical treatment options and the explosive growth of the medical tourism business have contributed to the sector's segment expansion. The leading companies profiled in the market research study on anal fistula treatment include Becton, Medtronic, Dickinson and Company, Gem Srl, Biolitec AG, BD, Johnson & Johnson Services, Inc., Mylan N.V., Takeda Pharmaceutical Company Limited, W. L. Gore & Associates, Cook, KARL STORZ SE & Co. KG, Novartis AG, Boehringer Ingelheim International GmbH, Pfizer.
Egypt Angelman Syndrome Therapeutics Market Analysis
Egypt During the forecast period of 2023?2030, The Angelman Syndrome Therapeutics Market is anticipated to increase from $xx Mn in 2023 to $xx Mn by 2030, recording a CAGR of xx percent. An uncommon inherited neuro-developmental condition called Angelman Syndrome is marked by a severe developmental delay, sleep issues, jerky movements, and a lot of laughter. As the illness is more common, there are more government measures to manage it. This has also helped with research and development for condition treatment. These factors collectively represent the Angelman Syndrome Therapeutics Market's driving forces. Boston Children's Hospital, the Angelman Syndrome Foundation, Rady Children's Hospital in San Diego, General Hospital Corporation, Cincinnati Children's Hospital Medical Center, and others are major competitors in the market for treating Angelman syndrome.
Egypt Ankylosing Spondylitis Therapeutics Market Analysis
Egypt Ankylosing Spondylitis Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Ankylosing spondylitis is a kind of arthritis that affects connective tissues. The sacroiliac joints, which connect the spine to the pelvis, become inflamed, but in extreme situations, the spine's bones might fuse together and become very inflexible. A rough estimate of 1.1 Mn Americans, or one out of every 200 adults, are impacted. Abbvie, Amgen, Eli Lilly, Janssen, Merck, Pfizer, Novartis, UCB, and many other leading companies are active in the ankylosing spondylitis global market. To increase their market share, these businesses engage in strategic alliances and acquisitions in addition to concentrating on research and development to bring novel therapies to market.
Egypt Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the Egypt Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Vitamin and Minerals Market, offering unmatched value, accuracy and expert insights.
Egypt Obesity Drugs Market Analysis
This report presents a strategic analysis of the Egypt Obesity Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Obesity Drugs Market, offering unmatched value, accuracy and expert insights.
Egypt ECG Equipments Market Analysis
Egypt ECG Equipment Market is expected to witness growth from $25 Mn in 2022 to $49 Mn in 2030 with a CAGR of 8.80% for the forecasted year 2022-30. The Egyptian government has made significant investments in the healthcare industry, including the construction of brand-new hospitals and centres as well as the remodelling of already-existing ones. As a result, the demand for ECG equipment has grown. The market is segmented by product type and by the end user. Some key players in this market include Wassenburg Medical, EMG-EP Technologies, Johnson & Johnson, Philipps Healthcare, Medtronic and Dexcom.
Egypt Teleradiology Market Analysis
Egypt's Teleradiology market size was valued at $7 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 13.2% from 2022 to 2030 and will reach $ 18 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Egypt teleradiology market will grow due to advancements in technology, such as electronic medical records (EMRs) and picture archiving and communication systems (PACS), which have made it easier to transmit and store medical images securely. The key market players are Alborg Laboratories & Radiology Services, Alfa Labs, Cairo Scan Radiology & Labs, Egypt Radiology Group, Ebtisama Radiology, MedMark Teleradiology, Mena Medical Solutions, Radiology Group, Telemedica Egypt and others.
Egypt Patient Engagement Solutions Market Analysis
Egypt's patient engagement solutions market is projected to grow from $47.63 Mn in 2022 to $133.03 Mn by 2030, registering a CAGR of 13.7% during the forecast period of 2022-2030. The main factors driving the growth would be as growing awareness, digital transformation of healthcare and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include AlMokhtabar, Curawella, Siemens Healthineers, Dedalus and Oracle.
Egypt Medical Devices Market Analysis
This report presents a strategic analysis of the Egypt Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Medical Devices Market, offering unmatched value, accuracy and expert insights.
Egypt Artificial Intelligence (AI) in Medical Imaging Market Analysis
Egypt,s Artificial Intelligence (AI) in Medical Imaging market size was valued at $4 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 36.9% from 2022 to 2030 and will reach $52 Mn. The market is segmented by AI technology, solution, modality, application, and end User. The demand for advanced medical imaging is increasing in Egypt due to the rising prevalence of chronic diseases and the aging population. Some of the key players in this market are InnoTech Medical Solutions, Nile University's Medical Image and Signal Processing (MISP) Lab, One Way Forward, BrainVISA Technologies, Scintilla for Medical Supplies, BMEYE, Crystal Technology, NewTech Medical Devices, Medispec, Faisal Misbah Mahmoud Radiology Center, and others.
Egypt ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
This report presents a strategic analysis of the Egypt ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market, offering unmatched value, accuracy and expert insights.
Egypt Medical and Diagnostic Laboratory Service Market Analysis
This report presents a strategic analysis of the Egypt Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy and expert insights.
Egypt Physiotherapy Market Analysis
This report presents a strategic analysis of the Egypt Physiotherapy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Physiotherapy Market, offering unmatched value, accuracy and expert insights.
Egypt Telemedicine Market Analysis
The Egypt telemedicine market size is at around $170 Mn in 2022 and is projected to reach $717 Mn in 2030, exhibiting a CAGR of 19.7% during the forecast period. The driving factors for potential growth in the Egyptian market are the prevalence of chronic diseases, the increasing cost of healthcare, the 5G network, and so on. The telemedicine industry is segmented by component, modality, application, and delivery mode. It also shows the competitive firms like Vezeeta, Clinido, Estshara, Schneider Electric, Siemens AG, and many more.
Egypt Home Healthcare Market Analysis
Egypt's home healthcare market was valued at $1.015 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.43% from 2022 to 2030 and will reach $2.08 Bn in 2030. The home healthcare market in Egypt has seen significant growth in recent years due to a variety of factors, including an ageing population, increasing rates of chronic diseases, and a growing awareness of the benefits of receiving medical care at home. The market is segmented by device type, service type, and indication type. The key players in Egypt’s home healthcare market are GE Healthcare, Abbott., Philips, Siemens Healthineers, and others.
Egypt Cardiovascular Diseases Therapeutics Market Analysis
The Egypt cardiovascular disease therapeutics market is expected to witness growth from $455 Mn in 2022 to $889 Mn in 2030 with a CAGR of 8.72% for the year 2022-2030. The increasing elderly population in Egypt and the government initiatives like Back to Rhyth and the Nile Heart Challenge to increase awareness about cardiovascular disease in Egypt are the major growth drivers of the market. The Egypt cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Copad Pharma, Menarini Pharmaceutical, and Novartis are the major players in the Egypt cardiovascular disease therapeutics market.
Egypt Depression Therapeutics Market Analysis
The Egypt depression therapeutics market is expected to witness growth from $28 Mn in 2022 to $48 Mn in 2030 with a CAGR of 6.7% for the forecasted year 2022-2030. The growing incidence of depression in Egypt and its improving health infrastructure has resulted in the growth of the market. The Egypt depression therapeutics market is segmented by drug type, therapies, indication, and by end users. FPi Future Pharmaceutical, Quadri Pharma, and GlaxoSmithKline are the major players in the Egypt depression therapeutics market.
Egypt Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt liver cancer therapeutics market will reach a value of $33.2 Mn from $8.2 Mn in 2022, growing at a CAGR of 19.1% during 2022-30. The liver cancer therapeutics market in Egypt is dominated by a few domestic pharmaceutical companies such as Pharco Pharmaceuticals, EIPICO, and Memac Pharma. The liver cancer therapeutics market in Egypt is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.